Industry-sponsored clinical trials a boon to US state economies

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Darren415)
(Image: Getty/Darren415)

Related tags: Clinical trials, PhRMA

Biopharmaceutical manufacturers in 2017 invested approximately $15.2bn at clinical trial sites around the country – resulting in a total economic impact of more than $42bn, says PhRMA director of public affairs.

These numbers are according to a new report from TEConomy Partners, supported by PhRMA, which estimates industry-sponsored clinical trial activity in the US in 2017.

The calculation of the overall economic impact includes the “ripple effect”​ of expenditures by clinical trial vendors and contractors as well as spending by industry and vendor employees, per the report.

“Most importantly, some 920,172 patients participated in more than 4,500 industry-led clinical trials across the United States during that same period,”​ Tiffany Haverly, director of public affairs, PhRMA, told us.

Haverly noted that some states “not typically associated with a large biopharmaceutical industry presence”​ supported many trials. For example, 1,016 in Tennessee.

According to the report, only six states had fewer than 100 clinical trials active in 2017.

The top five states with the most active trials were California, Florida, Texas, New York, and North Carolina.

“The biopharmaceutical industry brings profound value to patients through new treatments and cures for society’s most devastating and costly diseases and conditions, providing millions of patients with treatment options they would not otherwise have,”​ said Haverly.

“This report further underscores the positive impact industry-led clinical trials have on patients and local economies.”

Related topics: Clinical Development, Phase I-II

Related news

Related products

show more

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 21-Sep-2020 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more